ASH 2022
Interviews and expert commentary from ASH 2022 — study authors and key opinion leaders discuss the findings and their clinical implications.
Audio Journal of Oncology
Matthias Stelljes MD: Don't Delay Stem Cell Transplant For Patients with Relapsed or Refractory Acute Myeloid Leukemia
Don't Delay Stem Cell Transplant For Patients with Relapsed or Refractory Acute Myeloid Leukemia
23 January 2023
15:06
Audio Journal of Oncology
AUDIO JOURNAL OF ONCOLOGY—Ibrutinib Enables Transplant-Free Therapy for Mantle Cell Lymphoma
Ibrutinib Enables Transplant-Free Therapy for Mantle Cell Lymphoma NEW ORLEANS, USA—Many patients eligible for autologous stem cell transplantation for their mantle cell lymphoma (under current best p
20 January 2023
16:28
Audio Journal of Oncology
AUDIO JOURNAL OF ONCOLOGY—Fast Durable Responses to Bi-Specific Antibody Therapy In Heavily Pre-Treated Multiple Myeloma
January 10, 2023 Fast Durable Responses to Bi-Specific Antibody Therapy In Heavily Pre-Treated Multiple Myeloma INTERVIEW WITH: Ajai Chari MD, Associate Professor of Medicine and Director of Clinical
9 January 2023
20:54